WebOct 16, 2024 · Cytonics Stock Is an Investment in a ‘Super’ Protein At the heart of this biotechnology story is alpha-2-macroglobulin (A2M), which is a plasma protein found in the blood and is mainly ... WebCytonics’ Autologous Platelet Integrated Concentration (APIC™) System was developed with the intent of delivering high concentrations of A2M into damaged joints. The APIC™ system utilizes a proprietary filtration process to selectively concentrate A2M and remove inflammatory proteins from a patient’s own blood.
Cytonics Preclinical Study Results
WebCytonics Corporation is aiming to transform the way patients navigate osteoarthritis through its APIC system, which utilizes alpha-2-macroglobulin (A2M), and its new CYT-108 technology. Its technology has the power to drastically improve the … WebApr 5, 2024 · Cytonics, with a valuation cap of $32.4 million, is raising Series C funding on SeedInvest. The company is a leader in regenerative medicine and has developed innovative therapies for musculoskeletal diseases like osteoarthritis. Cytonics has created an Autologous Platelet Integrated Concentration system that concentrates A2M from … gordon\u0027s air conditioning and heating
What
WebOct 5, 2024 · Cytonics is a biotechnology firm specializing in regenerative medicine for osteoarthritis patients. According to Cytonics’ SeedInvest.com investor profile, over 27 … WebA2M functions byinhibiting destructive protease enzymes that chew up cartilage tissue. Our first therapeutic that gained FDA approval is the Autologous Protease Integrated … WebCytonics has developed breakthrough OA treatments based on a naturally occurring blood protein called “Alpha-2-macroglobulin” (A2M). A2M is a potent, broad-spectrum protease inhibitor that is able to inhibit the proteases involved in cartilage degradation in … gordon\\u0027s air fryer instructions